Pfizer Venture Investments Team
Photo of Rana Al-Hallaq, Partner at Pfizer Venture Investments
Rana Al-Hallaq
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York City
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Rana
Photo of Michael Baran, Partner at Pfizer Venture Investments
Michael Baran
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York City
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Michael
Photo of Barbara Dalton, Vice President at Pfizer Venture Investments
Barbara Dalton
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York (NY)
to see your intro paths to Barbara
Photo of Christopher O'Donnell, Partner at Pfizer Venture Investments
Christopher O'Donnell
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in Connecticut
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Pre-seed)
to see your intro paths to Christopher
Photo of Denis Patrick, Vice President at Pfizer Venture Investments
Denis Patrick
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Denis
Photo of Nikola Trbovic, Partner at Pfizer Venture Investments
Nikola Trbovic
Sweet spot: $10.0M
Range: $100K - $15.0M
Investors in New York City
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in BioTech (Pre-seed), Investors in BioTech (Pre-seed)
to see your intro paths to Nikola